Lamellolamellar sclerokeratoplasty. Where do we stand today?

被引:9
|
作者
Panda, A [1 ]
机构
[1] AIIAMS, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi, India
关键词
sclerokeratoplasty; Dessmarre's corneal dissector; King's clamp; glycerin-preserved; Mooren's ulcer; squamous cell carcinoma;
D O I
10.1038/eye.1999.55
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose To determine the efficacy of lamellar sclerokeratoplasty for patients with extensive cornea/corneoscleral lesions. Methods One hundred and sixty-six eyes with extensive corneal/corneoscleral lesions of different aetiology who were poor candidates for conventional lamellar keratoplasty/penetrating keratoplasty were selected for lamellar sclerokeratoplasty. Results Corneal clarity of 3+ or more was achieved in 62 eyes by a single procedure. In the remaining 104 eyes graft clarity was < 2+ due to post-surgical complications (n = 56) or remaining recipient deep opacity (n = 48). Conclusions Astigmatism, the bugbear of final visual achievement despite a clear graft, was not a frequent problem following lamellar sclerokeratoplasty. Similarly, a gain in visual acuity to 6/18 or more in 30% of eyes, cosmetic improvement in the majority of cases and prevention of recurrence of the original disease process in susceptible cases all point towards the safety and effectiveness of the procedure. Thus, lamellar sclerokeratoplasty should be considered as a management option for patients with extensive corneal/corneoscleral lesions.
引用
收藏
页码:221 / 225
页数:5
相关论文
共 50 条
  • [11] Smoking in Portugal: Where do we stand today?
    Pereira, Ana Margarida
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2019, 38 (08) : 595 - 597
  • [12] Oesophageal Adenocarcinomas: Where Do We Stand Today?
    Karstens, Karl-Frederick
    Stuben, Bjorn Ole
    Reeh, Matthias
    CANCERS, 2021, 13 (01)
  • [13] The fungal debate: Where do we stand today?
    Ebbens, F. A.
    Georgalas, C.
    Rinia, A. B.
    Van Drunen, C. M.
    Lund, V. J.
    Fokkens, W. J.
    RHINOLOGY, 2007, 45 (03) : 178 - 189
  • [14] Precision diabetes: Where do we stand today?
    Mohan, Viswanathan
    Unnikrishnan, Ranjit
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2018, 148 (05) : 472 - 475
  • [15] Blood substitutes:: where do we stand today?
    Kjellström, BT
    JOURNAL OF INTERNAL MEDICINE, 2003, 253 (05) : 495 - 497
  • [16] Child abuse - Where do we stand today?
    Holla, RG
    Gupta, A
    INDIAN PEDIATRICS, 2005, 42 (12) : 1251 - 1251
  • [17] HRT use: Where do we stand today?
    Stevenson, JC
    BRITISH JOURNAL OF CLINICAL PRACTICE, 1996, 50 (01): : 4 - 5
  • [18] "Elimination of lepra" - where do we stand today?
    Bendick, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2009, 7 : 41 - 42
  • [19] Asthma education: Where do we stand today and where do we want to be tomorrow?
    Schauerte, G.
    ALLERGOLOGIE, 2018, 41 (02) : 54 - 61
  • [20] Uterus transplantation:: where do we stand today and where should we go?
    Brannstrom, Mats
    Wranning, Caiza Almen
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (04) : 427 - 429